Overview
Rachel Longendyke, MD, is a pediatric endocrinologist at Children’s National Hospital. She graduated from medical school at the State University of New York at Buffalo and completed her pediatrics residency at Rainbow Babies & Children’s Hospital. Following residency, she graduated from the pediatric endocrinology fellowship at Children’s National. Her primary clinical interests involve type 1 diabetes, particularly increasing access to diabetes technology and working with children and their families to improve diabetes outcomes and increase quality of life.
Her clinical expertise encompasses Type 1 Diabetes (T1D).
Dr. Longendyke is board certified in Pediatrics: American Board Of Pediatrics, 2022. She is actively involved in clinical research, co-authoring 4 peer reviewed articles.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
Locations
111 Michigan Avenue Northwest, Washington, DC 20010
5285 Westview Drive, Suite 103, Frederick, MD 21703
9850 Key West Avenue, Rockville, MD 20850
111 Michigan Avenue Northwest, Childrens National Telemedicine, Washington, DC 20010
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Telehealth Video Visit
Andrew Dauber, MD, MMSc, is the chief of endocrinology at Children’s National Hospital. As a pediatric endocrinologist, Dr. Dauber works in all areas of pediatric endocrinology, but specializes in studying and treating growth disorders. Dr. Dauber has published more than 65 studies and regularly speaks at international pediatric endocrinology conferences, discussing a variety of topics, including clinical clues to identify rare genetic growth conditions, genetic factors that influence height and the timing of puberty, as well as novel genetic disorders that he has helped identify. He is the recipient of the 2020 Richard E. Weitzman Outstanding Early Career Investigator Award from the Endocrine Society for successfully applying innovative genetic technologies to pediatric endocrinology. With a medical degree and a Master’s of Medical Sciences in Clinical Investigation from Harvard Medical School, Dr. Dauber finds it natural to merge academic research with its clinical counterparts to accelerate cutting-edge treatment and multidisciplinary care. He is currently working with pediatric health centers to integrate genomics into patient registries and electronic health records, harnessing large data sets, including whole-exome sequences, to help clinicians identify and treat high-risk patients. Over the next few years, Dr. Dauber will create an endocrinology research program at Children’s National, transforming the type of care that children with endocrine disorders receive. This will make it easier for parents to find comprehensive resources for rare conditions, thyroid problems, growth disorders, early or delayed puberty, as well as type 1 and type 2 diabetes. Dr. Dauber also has experience with guiding joint infrastructures and engines of innovation. Previously, he served as the program director and director of translational research at the interdisciplinary Cincinnati Center for Growth Disorders at Cincinnati Children’s Hospital Medical Center. Additionally, he was the director of their Genomics First for Undiagnosed Diseases Program and guided medical residents and fellows as an associate professor of pediatrics at the University of Cincinnati. He held similar roles as the assistant medical director for the clinical research unit at Boston Children’s Hospital and as an assistant professor in pediatrics at Harvard Medical School. Dr. Dauber holds board certifications in pediatrics and pediatric endocrinology from the American Board of Pediatrics. He is an active member of and has received several awards and honors from the Endocrine Society, Pediatric Endocrine Society, European Society of Pediatric Endocrinology and the Society for Pediatric Research. Dr. Dauber is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Short Stature (Growth Disorders), Hypochondroplasia, Precocious Puberty, and Growth Hormone Deficiency (GHD). Dr. Dauber is board certified in Endocrinology Diabetes And Metabolism: American Board Of Pediatrics, 2011 and Pediatrics: American Board Of Pediatrics, 2007.
Office
Rachel Gafni is a Pediatric Endocrinologist practicing medicine in Bethesda, Maryland. Dr. Gafni is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Autosomal Dominant Hypocalcemia, Osteomalacia, Osteitis Fibrosa, Malnutrition, and Hormone Replacement Therapy (HRT).
Office
Deborah Merke is a Pediatric Endocrinologist practicing medicine in Bethesda, Maryland. Dr. Merke is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Congenital Adrenal Hyperplasia (CAH), Intersex, Ovarian Overproduction of Androgens, Addison's Disease, and Hormone Replacement Therapy (HRT).
Frequently Asked Questions about Dr. Rachel Longendyke
How do I make an appointment with Dr. Rachel Longendyke?
You can book an appointment with Dr. Rachel Longendyke by calling their office at 202-476-5631. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Rachel Longendyke a top-rated expert for Type 1 Diabetes (T1D)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Rachel Longendyke is classified as an Experienced expert for Type 1 Diabetes (T1D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Rachel Longendyke specialize in?
While Dr. Rachel Longendyke is a Pediatric Endocrinology, they have specific expertise in Type 1 Diabetes (T1D). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Endocrinology.
Does Dr. Rachel Longendyke participate in research or clinical trials?
Yes. Dr. Rachel Longendyke has published 4 articles and abstracts on conditions like Type 1 Diabetes (T1D). You can view a list of Dr. Rachel Longendyke's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Rachel Longendyke accept my insurance?
Dr. Rachel Longendyke accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 202-476-5631 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers